First Time Loading...

CRISPR Therapeutics AG
NASDAQ:CRSP

Watchlist Manager
CRISPR Therapeutics AG Logo
CRISPR Therapeutics AG
NASDAQ:CRSP
Watchlist
Price: 53.55 USD 0.49% Market Closed
Updated: May 10, 2024
CRSP
/
Income Statement
/
Revenue

CRISPR Therapeutics AG
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CRISPR Therapeutics AG
Revenue Peer Comparison

Comparables:
ADCT
ACIU
BSLN
IDIA
KURN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
CRISPR Therapeutics AG
NASDAQ:CRSP
Revenue
$371.2m
CAGR 3-Years
709%
CAGR 5-Years
160%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Revenue
$69.6m
CAGR 3-Years
N/A
CAGR 5-Years
129%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Revenue
CHf14.8m
CAGR 3-Years
-1%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Revenue
CHf157.6m
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
14%
Idorsia Ltd
SIX:IDIA
Revenue
CHf97.1m
CAGR 3-Years
60%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Revenue
CHf33.6m
CAGR 3-Years
103%
CAGR 5-Years
116%
CAGR 10-Years
N/A

CRISPR Therapeutics AG
Revenue Breakdown

Breakdown by Geography
CRISPR Therapeutics AG

Not Available

Breakdown by Segments
CRISPR Therapeutics AG

Total Revenue: 371.2m USD
100%
Collaboration Revenue: 370m USD
99.7%
Grant: 1.2m USD
0.3%

See Also

What is CRISPR Therapeutics AG's Revenue?
Revenue
371.2m USD

Based on the financial report for Dec 31, 2023, CRISPR Therapeutics AG's Revenue amounts to 371.2m USD.

What is CRISPR Therapeutics AG's Revenue growth rate?
Revenue CAGR 5Y
160%

Over the last year, the Revenue growth was 30 834%. The average annual Revenue growth rates for CRISPR Therapeutics AG have been 709% over the past three years , 160% over the past five years .

ALPHA SPREAD
Join more than 136,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.